These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 1553942)
21. The role of omeprazole in healing and prevention of reflux disease. Klinkenberg-Knol EC Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392 [TBL] [Abstract][Full Text] [Related]
22. [Omeprazole in the therapy of acid-induced diseases]. Simon B; Dammann HG; Müller P Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299 [TBL] [Abstract][Full Text] [Related]
23. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?]. Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181 [TBL] [Abstract][Full Text] [Related]
24. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study. Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986 [TBL] [Abstract][Full Text] [Related]
25. Fulminant hepatic failure caused by ecarazine hydrochloride (a hydralazine derivative). Tameda Y; Hamada M; Takase K; Nakano T; Kosaka Y Hepatology; 1996 Mar; 23(3):465-70. PubMed ID: 8617425 [TBL] [Abstract][Full Text] [Related]
27. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463 [TBL] [Abstract][Full Text] [Related]
28. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al]. Miederer SE Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976 [No Abstract] [Full Text] [Related]
29. [Anti-H2 and omeprazole in brief therapy of peptic ulcer]. Piai G; Sabbatini F; Mazzacca G Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622 [No Abstract] [Full Text] [Related]
30. Electrolyte disturbance with omeprazole therapy. Melville C; Shah A; Matthew D; Milla P Eur J Pediatr; 1994 Jan; 153(1):49-51. PubMed ID: 8313925 [TBL] [Abstract][Full Text] [Related]
31. [Gynecomastia induced by omeprazole]. Pedrosa M; Sancho A; Benavent J; Casajuana J Med Clin (Barc); 1994 Mar; 102(11):435. PubMed ID: 8183005 [No Abstract] [Full Text] [Related]
32. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451 [TBL] [Abstract][Full Text] [Related]
33. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases]. Koop H; Katschinski M; Arnold R Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214 [TBL] [Abstract][Full Text] [Related]
34. Omeprazole therapy in resistant reflux disease. Waldum HL; Brenna E Ann Intern Med; 1995 Feb; 122(3):236; author reply 236-7. PubMed ID: 7888009 [No Abstract] [Full Text] [Related]